Search Constraints
Search Results
Select an image to start the slideshow
Loss of the Cortical Monoamine Projection Systems in the
MPTP-treated Nonhuman Primate Model of Parkinson's Disease
1 of 19
RING FINGER PROTEIN 11 (RNF11) MEDIATES NF-κB SIGNALING AND
DOPAMINERGIC NEURODEGENERATION
2 of 19
Pesticides and Parkinson's disease: Attributable Risk of
Occupational Exposure and Neurochemical Analysis of Sub-Chronic
Environmental Exposure
3 of 19
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
4 of 19
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
5 of 19
A role for the synaptic vesicle glycoprotein 2C (SV2C) in
dopamine homeostasis and Parkinson's disease
6 of 19
Optimized Delivery of C3 Transferase by Lentiviral Vectors forCNS Injury Therapy
7 of 19
Effects of Dopamine D1-Like Receptor Activation in the Internal Pallidal Segment and the Substantia Nigra Pars Reticulata of Normal and Parkinsonian Primates
8 of 19
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
9 of 19
Synaptic Vesicle Glycoprotein 2C (SV2C) in Parkinson's Disease-Related Striatal Vesicular Dysfunction
10 of 19
The impact of LRRK2 expression and kinase activity in gene by environment mouse models of Parkinson’s disease
11 of 19
Gene-Environment Interplay in Parkinson’s Disease Pathogenesis: The Role of Gastrointestinal Inflammation and Regulator of G-protein Signaling 10 in the Gut-Brain Axis
12 of 19
Abnormal muscle activity during balance before and after an exercise-based balance rehabilitation in people with Parkinson’s disease
13 of 19
LRRK2 and Environmental Effects on Dopamine Systems within the Gut-Brain Axis: A Parkinson’s Disease Pathology Focus
14 of 19
Ultrastructural Plasticity of Pallidothalamic GABAergic Terminals in Parkinson’s Disease: A 3D Electron Microscopy Study in the Parvocellular Ventral Anterior and Centromedian Thalamic Nuclei in MPTP-Treated Parkinsonian Monkeys
15 of 19
Innate and Adaptive Immune System Crosstalk in Parkinson's Disease
16 of 19
Cannabinoid type 2 receptors regulate striatal inflammation following alpha synuclein-induced nigral degeneration in rat model of Parkinson’s disease
17 of 19
The Effects of Chronic, Oral Deltamethrin Exposure on Nigrostriatal Dopamine Receptors: A Model for Pyrethroid Toxicity in Adults
18 of 19
Noradrenergic dysfunction in neurodegenerative disease
19 of 19